Tim Curtis is a Professor at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, where he leads research on diabetic retinopathy mechanisms and novel therapeutics. His work focuses on mitochondrial dynamics, vascular physiology, and neuroprotection in ocular diseases. He serves as Academic Lead for the Advanced Imaging Core Technology Unit and has directed multiple projects on retinal endothelial dysfunction funded by organizations including Diabetes UK and Wellcome Trust. Research spans molecular pathways in diabetic retinopathy, TRP channel pharmacology, and mitochondrial quality control. Recent work investigates therapeutic targets like TRPV4 channels and mitophagy activators. Articles demonstrate consistent focus on retinal neurovascular unit protection through metabolic modulation and ion channel regulation. Professor Curtis mentors graduate students in vascular physiology, diabetic retinopathy, and ocular therapeutics. His laboratory employs interdisciplinary approaches including live-cell imaging, electrophysiology, and 3D electron microscopy to study retinal pathophysiology.








